Medicare Opens Obesity-Drug Access for Seniors, Yet Awareness Is Lagging
TL;DR Summary
Medicare’s Bridge demonstration program will start covering obesity medications for eligible beneficiaries with a $50 monthly copay, starting July 1, expanding access to GLP-1 drugs like Wegovy and Zepbound; however, awareness among seniors is low, enrollment isn’t automatic and requires a prescription plus prior authorization, and public outreach is being scaled up after launch as CMS and drugmakers prepare for possible demand through 2027.
- Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet CNBC
- Medicare to Cover GLP-1 Weight-Loss Drugs For $50 a Month: See If You’re Eligible TODAY.com
- Medicare to cover Ozempic-style weight loss drugs for $50 a month starting July 1: Who qualifies MassLive
- Walmart expands weight management services for Medicare patients Modern Healthcare
- Medicare will soon offer some older Oregonians weight loss drugs for $50 a month. Here’s how it works OregonLive.com
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
5 min
vs 6 min read
Condensed
94%
1,161 → 64 words
Want the full story? Read the original article
Read on CNBC